Your browser doesn't support javascript.
loading
Immune checkpoint inhibitors and timing of administration - Authors' reply.
Qian, David C; Buchwald, Zachary S.
Affiliation
  • Qian DC; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA.
  • Buchwald ZS; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA. Electronic address: zachary.scott.buchwald@emory.edu.
Lancet Oncol ; 23(2): e57, 2022 02.
Article in En | MEDLINE | ID: mdl-35114126
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immune Checkpoint Inhibitors / Antibodies, Monoclonal Limits: Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immune Checkpoint Inhibitors / Antibodies, Monoclonal Limits: Humans Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: United States Country of publication: United kingdom